PARTNERSHIP TO FIGHT INFECTIOUS DISEASE

EIN: 872803404

WASHINGTON, DC

Total Revenue
$2,227,000
Total Expenses
$2,229,115
Total Assets
$260,863
Net Assets
$260,025
🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Sign In — Free (10 views/day)

Financial Trends

Organization Details

Formation Year
2021
Legal Domicile
DC
Principal Officer
CANDACE DEMATTEIS
Phone
2028274800
Tax Period
2024-01-01 to 2024-12-31

PARTNERSHIP TO FIGHT INFECTIOUS DISEASE, founded in 2021, is a community nonprofit that reported $2.2M in total revenue in fiscal year 2024.

Mission

TO ADDRESS THE NEED TO FOCUS ON VACCINE CONFIDENCE, OVERCOME VACCINE MISINFORMATION AND SEEK THE PASSAGE OF AMR LEGISLATION.

Program Service Accomplishments

Program 1
Expenses: $724,167

EDUCATE PUBLIC AND ADVANCE LEGISLATION ADDRESSING GROWING ANTIMICROBIAL RESISTANCE

Program 2
Expenses: $724,166

WORK WITH POLICYMAKERS TO ENSURE A STRONG POLICY IN PLACE TO PREPARE FOR THE NEXT PANDEMIC

Program 3
Expenses: $724,167

BUILD CONFIDENCE IN AND OVERCOME HESITANCY IN VACCINES AND OVERCOME VACCINE MISINFORMATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Sign In — Free (10 views/day)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,227,000
Program Service Revenue $0
Investment Income $0
Other Revenue $0
TOTAL REVENUE $2,227,000

Expense Breakdown

Grants Paid $0
Salaries & Benefits $0
Fundraising Expenses $0
Program Expenses $2,172,500
Other Expenses $2,229,115
TOTAL EXPENSES $2,229,115

Year-over-Year Comparison

2024 2023 Change
Revenue $2,227,000 $2,295,000 0.0%
Expenses $2,229,115 $2,136,947 +0.0%
Net Income $-2,115 $158,053 -1.0%
Key Indicators
✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required
🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Sign In

Governance

Voting Members
3
Independent Members
2
Employees
N/A
Volunteers
N/A

Governance Policies

✓ Conflict of Interest Policy
✓ Whistleblower Policy
✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School
✗ Operated a Hospital
✗ Provided First Class Travel
✗ Reported Conflict of Interest
✗ Reported Asset Diversion
✗ Excess Benefit Transaction
✗ Made Political Expenditures
✗ Engaged in Lobbying
✗ Operated Donor Advised Fund
✗ Maintained Art Collections
✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers
3
$120,000
Total Directors
3
$120,000
Key Employees
0
$0
Highest Compensated
0
reported
Name Title Hours/Week Role Reportable Comp Other Comp Total
CANDACE DEMATTEIS TREASURER 4.00
Officer Director
$120,000 $0 $120,000
REBECCA SNEAD SECRETARY 1.00
Officer Director
$0 $0 $0
BURTON ELLER PRESIDENT 1.00
Officer Director
$0 $0 $0
Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year Revenue Expenses Assets Net Income
2024 $2,227,000 $2,229,115 $260,863 $-2,115
2023 $2,295,000 $2,136,947 $462,140 $158,053
Explore More Nonprofits
→Top 100 Nonprofits in District of Columbia →Largest U.S. Nonprofits →Best Rated Nonprofits →Most Efficient Nonprofits

Compare PARTNERSHIP TO FIGHT INFECTIOUS DISEASE with other nonprofits in District of Columbia and across the country.

We Value Your Privacy
We use cookies and similar technologies to analyze site traffic and improve your experience. By clicking "Accept All", you consent to our use of cookies for analytics and measurement.